investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Michael J Eck

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Trachea, bronchus and lung

Donald W. Kufe

Functional role of the MUC1-C oncoprotein in non-small cell lung cancer

Trachea, bronchus and lung

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Charles M. Rudin

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Trachea, bronchus and lung

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Jeffrey Mackeigan

Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer

Trachea, bronchus and lung

Pathology

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology

Dolph Hatfield

Role of Selenium in Development and Health

Trachea, bronchus and lung

Sign Up For Updates

Stay up to date with what's going on with The GO Map.